4 views left Get unlimited views with a free account

Take your business to the next level. Explore the latest trends and actionable insights to inform business strategy and pinpoint opportunities and risks.

Number of ongoing Clinical Trials (for drugs) involving Synovial Sarcoma by Phase

Industry: Pharmaceuticals
Current: Other Industry Indicators

There are currently 218 ongoing clinical trials involving Synovial Sarcoma
Of the 218 trials,73 trials are in Phase I
Furthermore, 66 trials are in Phase II

Number of ongoing Clinical Trials (for drugs) involving Synovial Sarcoma by Phase

View as table

The global pharmaceutical industry is steadily developing new drugs for Synovial Sarcoma, an oncology condition. The largest number of ongoing clinical trials for Synovial Sarcoma is conducted in North America. Asia-Pacific and Europe are among some of the other prominent regions engaged in Synovial Sarcoma-related drug trials.

Sun Yat-sen University: The leading ongoing Synovial Sarcoma related clinical trial sponsor

Sun Yat-sen University is the top sponsor for Synovial Sarcoma-related ongoing clinical trials.

Adaptimmune Therapeutics Plc, Epizyme Inc, GlaxoSmithKline Plc, Fred Hutchinson/University of Washington Cancer Consortium, and National Cancer Institute US are among other notable clinical trial sponsors involved in Synovial Sarcoma. A clinical trial sponsor can be a Company, Government, Individual, or Institution.